文献速递肺外科心外重症与机械循环支持

心脏-肺联合移植的现代结局:评估美国更新分配系统的影响

Modern outcomes of heart-lung transplantation: assessing the impact of the updated US allocation system.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究纳入2012至2021年登记的511例成人心脏-肺联合移植候选者,按分配政策时代分层。新分配系统时代移植可能性增加(aSHR 1.60),等待期死亡率降低(aSHR 0.43),尽管缺血时间更长且术前VA-ECMO使用增加,早期移植后生存相当。

要点

  • 新分配系统时代移植可能性增加(aSHR 1.60,95%CI 1.23-2.07,P<0.01)。
  • 新分配系统时代等待期死亡率降低(aSHR 0.43,95%CI 0.25-0.73,P<0.01)。
  • 尽管缺血时间更长和VA-ECMO使用增加,早期移植后生存相当。

核心结论

  • 分配政策变化改善了心脏-肺联合移植候选者的等待期结局,尽管缺血时间增加和ECMO使用增加,早期移植后生存相当。

研究设计与样本

  • 纳入2012至2021年间登记的成人心脏-肺联合移植候选者,按登记时代分层,使用竞争风险回归评估等待期结局,Cox比例风险回归确定移植后死亡危险因素。

主要发现

  • 共纳入511例患者,其中时代1有295例(57.8%),时代2有216例(42.2%)。
  • 时代2与移植可能性增加相关(aSHR 1.60,95%CI 1.23-2.07,P<0.01)。
  • 时代2与等待期死亡率降低相关(aSHR 0.43,95%CI 0.25-0.73,P<0.01)。
  • 尽管时代2缺血时间更长且术前VA-ECMO使用增加,早期移植后生存相当。
  • 预测心脏质量比<0.8(HR 3.24,P=0.01)、呼吸机支持(HR 3.83,P<0.01)和更长的缺血时间(HR 1.80,P<0.01)独立预测死亡;高中心容量的手术(HR 0.36,P=0.04)与死亡率降低相关;现代时代ECMO使用不能预测死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In 2018, the United Network for Organ Sharing modified their heart allocation policy to reduce waitlist mortality and prioritize patients with the greatest acuity. Considering declining rates of combined heart-lung transplantation, this study sought to investigate the impact of the new allocation system on waitlist and post-transplant outcomes of patients listed for combined heart-lung transplantation. METHODS: Adult patients listed for combined heart-lung transplant between 2012 and 2021 were included. Patients were stratified according to listing era. Competing risk regression was used to assess waitlist outcomes. Cox proportional hazards regression was used to establish risk factors for post-transplant mortality. RESULTS: A total of 511 patients were included, of whom 295 (57.8%) were listed in era 1 and 216 (42.2%) in era 2. Era 2 was associated with increased likelihood of transplant (adjusted standard hazard ratio (aSHR): 1.60 [1.23-2.07]; P < 0.01) and decreased waitlist mortality (aSHR: 0.43 [0.25-0.73]; P < 0.01). Despite longer ischaemic times and increased use of preoperative veno-arterial extracorporeal membrane oxygenation (ECMO) in era 2, early post-transplant survival was equivalent. Predicted heart mass ratio <0.8 (Hazard ratio (HR); 3.24; P = 0.01), ventilator support (HR: 3.83; P < 0.01) and greater ischaemic times (HR: 1.80; P < 0.01) independently predicted the mortality. Procedures at high centre volumes (HR: 0.36; P = 0.04) were associated with decreased mortality. Use of ECMO was not predictive of mortality in the modern era. CONCLUSIONS: The allocation policy change has led to improvements in waitlist outcomes in patients listed for heart-lung transplantation. Despite increased ischaemic times and use of ECMO, early post-transplant survival was equivalent.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Shin M, Iyengar A, Helmers MR, et al. Modern outcomes of heart-lung transplantation: assessing the impact of the updated US allocation system. Eur J Cardiothorac Surg. 2022. PMID: 36472453. doi:10.1093/ejcts/ezac559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。